LISANTI CAPITAL GROWTH, LLC – Intra-Cellular Therapies, Inc. Transaction History
LISANTI CAPITAL GROWTH, LLC portfolio value:
$3.93M
portfolio value
LISANTI CAPITAL GROWTH, LLC quarter portfolio value change:
-18.48%
quarter
Intra-Cellular Therapies, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -74.20% | -243.31K shares | -14.78M | $46.53 | 84.58K |
| Q2 2022 | share | Increase | +17.78% | 49.49K shares | 1.68M | $57.08 | 327.89K |
| Q1 2022 | share | Increase | 0.00% | 278.39K shares | 17.03M | $61.19 | 278.39K |
| Q3 2016 | share | Decrease | -100.00% | -12.26K shares | -476K | $15.24 | 0 |
| Q2 2016 | share | Increase | 0.00% | 12.26K shares | 476K | $38.82 | 12.26K |